Cargando…
Circulating acyl-CoA-binding protein/diazepam-binding inhibitor in gestational diabetes mellitus
BACKGROUND: Acyl-CoA-binding protein (ACBP)/diazepam-binding inhibitor has recently been characterized as an endocrine factor affecting energy balance and lipid metabolism. However, regulation of ACBP in women with gestational diabetes mellitus (GDM) during pregnancy, as well as postpartum, has not...
Autores principales: | Schürfeld, Robin, Baratashvili, Ekaterine, Würfel, Marleen, Blüher, Matthias, Stumvoll, Michael, Tönjes, Anke, Ebert, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591366/ https://www.ncbi.nlm.nih.gov/pubmed/37872629 http://dx.doi.org/10.1186/s12958-023-01152-z |
Ejemplares similares
-
Renal function is a major predictor of circulating acyl-CoA-binding protein/diazepam-binding inhibitor
por: Schürfeld, Robin, et al.
Publicado: (2023) -
Adipokines as Clinically Relevant Therapeutic Targets in Obesity
por: Würfel, Marleen, et al.
Publicado: (2023) -
Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)
por: Joseph, Adrien, et al.
Publicado: (2020) -
RICE ACYL-COA-BINDING PROTEIN6 Affects Acyl-CoA Homeostasis and Growth in Rice
por: Meng, Wei, et al.
Publicado: (2020) -
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
por: Joseph, Adrien, et al.
Publicado: (2021)